1. Evasion of the complement system by Leishmania through the uptake of factor H, a complement regulatory protein
- Author
-
Ricardo Toshio Fugiwara, Leonardo Barbosa Koerich, Mauricio Roberto Viana Sant'Anna, Marcos H. Pereira, Natália Alvim Araújo Saab, Ricardo Nascimento Araújo, Nelder F. Gontijo, Alexandre Alves Sousa Nascimento, Grasielle Caldas D’Ávila Pessoa, and Adalberto Alves Pereira Filho
- Subjects
Regulation of gene expression ,Protease ,biology ,Chemistry ,Veterinary (miscellaneous) ,medicine.medical_treatment ,Proteins ,Complement factor I ,Complement System Proteins ,Leishmania ,biology.organism_classification ,Complement system ,Infectious Diseases ,Dogs ,Biochemistry ,Insect Science ,Complement Factor H ,parasitic diseases ,Blocking antibody ,medicine ,Animals ,Parasitology ,Leishmania infantum ,Receptor - Abstract
Escaping the complement system is an important step in the establishment of infections. Some pathogens have acquired the ability to inactivate the complement system to ensure successful infection. This has been observed in parasites from the genus Leishmania, which inactivate C3b molecules deposited on their surface through the membrane protease GP63. In the present study, we describe a new mechanism that also acts through C3b inactivation. This mechanism involves the binding of the complement regulatory molecule factor H from serum. Factor H signals a plasma protease (factor I) to inactivate C3b molecules deposited on the surface of the parasites. According to our results, Leishmania infantum, L. amazonensis, and L. braziliensis recruit factor H from human serum. The absorption of factor H by L. infantum was studied in detail to better understand how it works. L. infantum binds factor H from human serum and factor H-like proteins from dog serum. When exposed to purified factor H, promastigotes bind this regulatory molecule and inactivate C3b in the presence of factor I. This indicates the existence of an as yet unidentified factor H-binding outer surface molecule functioning as a receptor. The two mechanisms (GP63 and factor H binding) work independently, as Leishmania promastigotes with inhibited GP63 can easily inactivate C3b molecules on the surface of the parasite. The identification of the factor H receptor could lead to the development of a vaccine target for leishmaniasis control, as blocking antibodies to factor H binding could impair the mechanism of C3b inactivation, making the parasite more susceptible to the complement system.
- Published
- 2021